# Prime Medicine, Inc.: filings

PRME · Nasdaq · CIK 1894562 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/prme.md) · [Financials](/companies/prme/financials.md) · [Filings](/companies/prme/filings.md) · [Insiders](/companies/prme/insiders.md)

## Reports and events: 70 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 118, 8-K 42, 3 20, 10-Q 12, UPLOAD 8, CORRESP 7, DEFA14A 7, DRS/A 7, 144 6, DEF 14A 5, S-8 5, SC 13G/A 5, 10-K 4, 424B5 4, ARS 4, DRSLTR 4, EFFECT 4, SC 13G 4, SCHEDULE 13G/A 4, FWP 3, PRE 14A 2, S-1/A 2, S-3 2, SEC STAFF LETTER 2, 3/A 1, 424B4 1, 4/A 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, POS AM 1, POSASR 1, S-1 1, S-1MEF 1, S-3ASR 1, SC 13D 1, SC 13D/A 1, SCHEDULE 13D/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 08:03 ET | [10-Q](/filings/0001628280-26-053883.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053883 |
| 2026-08-06 | 08:02 ET | [8-K](/filings/0001628280-26-053878.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053878 |
| 2026-07-08 | 08:02 ET | [8-K](/filings/0001628280-26-047590.md) | 8.01 Other events | 0001628280-26-047590 |
| 2026-06-08 | 16:10 ET | [8-K](/filings/0001628280-26-041543.md) | 5.07 Shareholder vote results | 0001628280-26-041543 |
| 2026-05-07 | 08:15 ET | [10-Q](/filings/0001628280-26-031726.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031726 |
| 2026-05-07 | 08:10 ET | [8-K](/filings/0001628280-26-031719.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-031719 |
| 2026-04-23 | 08:35 ET | [DEF 14A](/filings/0001628280-26-026697.md) | Proxy statement, period 2025-12-31 | 0001628280-26-026697 |
| 2026-04-16 | 08:15 ET | [8-K](/filings/0001628280-26-025372.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-025372 |
| 2026-03-03 | 08:19 ET | [10-K](/filings/0001628280-26-013569.md) | Annual report, period 2025-12-31 | 0001628280-26-013569 |
| 2026-03-03 | 08:02 ET | [8-K](/filings/0001628280-26-013565.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-013565 |
| 2026-01-12 | 08:31 ET | [8-K](/filings/0001628280-26-001773.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-001773 |
| 2025-11-07 | 07:35 ET | [10-Q](/filings/0001628280-25-050422.md) | Quarterly report, period 2025-09-30 | 0001628280-25-050422 |
| 2025-11-07 | 07:27 ET | [8-K](/filings/0001628280-25-050415.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-050415 |
| 2025-09-08 | 08:04 ET | [8-K](/filings/0001894562-25-000056.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001894562-25-000056 |
| 2025-08-11 | 21:48 ET | [SCHEDULE 13D/A](/filings/0001072613-25-000536.md) | Ownership report, active investor, amended | 0001072613-25-000536 |
| 2025-08-07 | 08:36 ET | [10-Q](/filings/0001628280-25-038619.md) | Quarterly report, period 2025-06-30 | 0001628280-25-038619 |
| 2025-08-07 | 08:33 ET | [8-K](/filings/0001628280-25-038617.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-038617 |
| 2025-08-05 | 16:23 ET | [8-K](/filings/0001628280-25-037840.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001628280-25-037840 |
| 2025-07-31 | 17:16 ET | [8-K](/filings/0001628280-25-037076.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-037076 |
| 2025-07-30 | 16:04 ET | [8-K](/filings/0001628280-25-036705.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-036705 |
| 2025-07-15 | 16:04 ET | [8-K](/filings/0001628280-25-034971.md) | 5.02 Departure or appointment of officers or directors | 0001628280-25-034971 |
| 2025-07-14 | 16:38 ET | [DEF 14A](/filings/0001193125-25-158716.md) | Proxy statement, period 2025-08-01 | 0001193125-25-158716 |
| 2025-06-05 | 16:11 ET | [8-K](/filings/0001628280-25-029646.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-25-029646 |
| 2025-05-19 | 09:09 ET | [8-K](/filings/0001193125-25-122156.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-122156 |
| 2025-05-08 | 08:08 ET | [10-Q](/filings/0001628280-25-023486.md) | Quarterly report, period 2025-03-31 | 0001628280-25-023486 |
| 2025-05-08 | 08:05 ET | [8-K](/filings/0001628280-25-023482.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-023482 |
| 2025-04-22 | 06:07 ET | [DEF 14A](/filings/0001628280-25-018704.md) | Proxy statement, period 2024-12-31 | 0001628280-25-018704 |
| 2025-03-18 | 07:15 ET | [8-K](/filings/0001193125-25-056122.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-056122 |
| 2025-02-28 | 08:13 ET | [10-K](/filings/0001628280-25-008884.md) | Annual report, period 2024-12-31 | 0001628280-25-008884 |
| 2025-02-28 | 08:02 ET | [8-K](/filings/0001628280-25-008873.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-008873 |
| 2025-01-13 | 08:01 ET | [8-K](/filings/0001628280-25-001244.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-001244 |
| 2024-11-22 | 17:32 ET | [SC 13D/A](/filings/0001072613-24-000898.md) | Ownership report, active investor, amended | 0001072613-24-000898 |
| 2024-11-12 | 16:10 ET | [10-Q](/filings/0001628280-24-047130.md) | Quarterly report, period 2024-09-30 | 0001628280-24-047130 |
| 2024-11-12 | 16:06 ET | [8-K](/filings/0001628280-24-047119.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-047119 |
| 2024-10-24 | 08:04 ET | [8-K](/filings/0001628280-24-043500.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-043500 |
| 2024-09-30 | 07:38 ET | [8-K](/filings/0001628280-24-041541.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-041541 |
| 2024-08-08 | 08:26 ET | [10-Q](/filings/0001628280-24-035893.md) | Quarterly report, period 2024-06-30 | 0001628280-24-035893 |
| 2024-08-08 | 08:08 ET | [8-K](/filings/0001628280-24-035886.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-035886 |
| 2024-06-12 | 16:10 ET | [8-K](/filings/0001628280-24-027816.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-24-027816 |
| 2024-05-21 | 16:03 ET | [8-K](/filings/0001628280-24-024530.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-24-024530 |
| 2024-05-10 | 08:22 ET | [10-Q](/filings/0001628280-24-022473.md) | Quarterly report, period 2024-03-31 | 0001628280-24-022473 |
| 2024-05-10 | 08:05 ET | [8-K](/filings/0001628280-24-022466.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-022466 |
| 2024-04-29 | 16:03 ET | [DEF 14A](/filings/0001628280-24-018977.md) | Proxy statement, period 2024-06-12 | 0001628280-24-018977 |
| 2024-03-01 | 08:04 ET | [10-K](/filings/0001628280-24-008116.md) | Annual report, period 2023-12-31 | 0001628280-24-008116 |
| 2024-03-01 | 08:01 ET | [8-K](/filings/0001628280-24-008113.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-008113 |
| 2024-02-22 | 21:31 ET | [SC 13D](/filings/0001072613-24-000265.md) | Ownership report, active investor | 0001072613-24-000265 |
| 2024-02-16 | 06:23 ET | [8-K](/filings/0001193125-24-038016.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-038016 |
| 2024-02-14 | 16:12 ET | [8-K](/filings/0001628280-24-004785.md) | 2.02 Results of operations | 0001628280-24-004785 |
| 2024-01-08 | 08:01 ET | [8-K](/filings/0001193125-24-003924.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-003924 |
| 2024-01-05 | 17:03 ET | [8-K](/filings/0001628280-24-000676.md) | 8.01 Other events | 0001628280-24-000676 |

Page 1 of 2. [Older](/companies/prme/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.